​

National Health Investors (NHI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NHI Stock Forecast

National Health Investors (NHI) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $85.00, with a high of $92.00 and a low of $78.00. This represents a 26.19% increase from the last price of $67.36.

$55 $63 $71 $79 $87 $95 High: $92 Avg: $85 Low: $78 Last Closed Price: $67.36

NHI Stock Rating

National Health Investors stock's rating consensus is Hold, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (33.33%), 4 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 6 0 4 2 Strong Sell Sell Hold Buy Strong Buy

NHI Forecast vs Benchmarks

TypeNameUpside
StockNational Health Investors26.19%
SectorReal Estate Stocks 14.90%
IndustryHealthcare REIT Stocks10.70%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$71.60
Last Closing Price$67.36$67.36$67.36
Upside/Downside--6.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25134--8
Dec, 24134--8
Nov, 242391-15
Oct, 242491-16
Sep, 242491-16
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Joshua DennerleinBank of America Securities$92.00$84.718.61%36.58%
Aug 30, 2024Michael LewisTruist Financial$78.00$80.74-3.39%15.80%
Apr 03, 2024Michael LewisTruist Financial$58.00$59.89-3.16%-13.90%
Mar 12, 2024John KimNational Bank$67.00$59.5612.49%-0.53%
Feb 26, 2024Connor SiverskyWells Fargo$63.00$57.769.07%-6.47%
Dec 09, 2022Tayo OkusanyaNational Bank$58.00$56.542.58%-13.90%
Sep 26, 2022Truist Financial$61.00$55.4410.03%-9.44%
Apr 18, 2022John KimBMO Capital$61.00$54.5911.74%-9.44%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 01, 2024Wells FargoOverweightEqual-Weightdowngrade
Sep 24, 2024Bank of America SecuritiesBuyinitialise
Aug 23, 2024Wells FargoOverweightOverweighthold
Apr 19, 2024BMO CapitalOutperformOutperformhold
Mar 19, 2024WedbushOutperformNeutraldowngrade
Mar 12, 2024BMO CapitalMarket PerformOutperformupgrade
Feb 26, 2024Wells FargoEqual-WeightOverweightupgrade
Dec 01, 2023Wells FargoEqual-WeightEqual-Weighthold
Dec 09, 2022Credit SuisseNeutralupgrade
Jun 21, 2022BMO CapitalMarket Performdowngrade

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.03$1.36$0.51$3.13-----
Avg Forecast$4.30$3.11$2.17$3.07$2.91$3.14$3.34$3.36-
High Forecast$3.91$2.83$1.95$3.05$2.90$3.09$3.28$2.93-
Low Forecast$5.00$3.62$2.68$3.08$2.94$3.22$3.45$4.39-
Surprise %-29.53%-56.27%-76.50%1.95%-----

Revenue Forecast

$200M $240M $280M $320M $360M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$332.81M$298.71M$278.19M$319.83M-----
Avg Forecast$314.79M$288.95M$226.00M$259.99M$267.97M$279.05M$279.18M$258.41M$259.53M
High Forecast$292.97M$268.93M$208.19M$259.39M$254.76M$250.87M$251.75M$233.03M$234.04M
Low Forecast$354.43M$325.34M$266.57M$261.54M$277.23M$341.33M$344.73M$319.09M$320.47M
Surprise %5.73%3.38%23.10%23.02%-----

Net Income Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$135.37M$62.19M$23.06M$135.65M-----
Avg Forecast$168.07M$132.59M$98.03M$135.60M$126.68M$136.94M$146.20M$168.09M-
High Forecast$134.45M$106.07M$78.43M$108.48M$125.80M$134.01M$142.49M$127.17M-
Low Forecast$201.68M$159.11M$117.64M$162.72M$127.52M$139.86M$149.90M$190.29M-
Surprise %-19.45%-53.10%-76.48%0.04%-----

NHI Forecast FAQ

Is National Health Investors stock a buy?

National Health Investors stock has a consensus rating of Hold, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that National Health Investors is a neutral investment for most analysts.

What is National Health Investors's price target?

National Health Investors's price target, set by 6 Wall Street analysts, averages $85 over the next 12 months. The price target range spans from $78 at the low end to $92 at the high end, suggesting a potential 26.19% change from the previous close price of $67.36.

How does National Health Investors stock forecast compare to the average forecast of its sector, industry, and investment themes?

National Health Investors stock forecast shows a 26.19% upside, outperforming the average forecast for the real estate stocks sector (14.90%) and outperforming the healthcare reit stocks industry (10.70%).

What is the breakdown of analyst ratings for National Health Investors over the past three months?

  • January 2025: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 13.33% Strong Buy, 20.00% Buy, 60.00% Hold, 6.67% Sell, 0% Strong Sell.

What is National Health Investors’s EPS forecast?

National Health Investors's average annual EPS forecast for its fiscal year ending in December is 2.91 for 2024, a -7.03% decrease from the reported $3.13 in 2023. The prediction for 2025 is $3.14, $3.34 for 2026, $3.36 for 2027, and $0 for 2028.

What is National Health Investors’s revenue forecast?

National Health Investors's average annual revenue forecast for its fiscal year ending in December is $267.97M for 2024, a -16.22% decrease from the reported $319.84M in 2023. The forecast for 2025 is $279.05M, $279.18M for 2026, $258.41M for 2027, and $259.53M for 2028.

What is National Health Investors’s net income forecast?

For its fiscal year ending in December, National Health Investors's average annual net income forecast is $126.68M for 2024, reflecting a -6.62% decrease from the reported $135.65M in 2023. The projection for 2025 is $136.94M, $146.2M for 2026, $168.09M for 2027, and $0 for 2028.